BRAND_ANALYSIS #MODERNA HEALTH & PHARMA #26 OF 26 IN HEALTH & PHARMA ALIGNED

Moderna

· Public · Updated 25 May 2026 11:16 UTC
#1168 of 1208 overall by tension · #26 of 26 in Health & Pharma
2 Aligned
The Balanced
Analysis

A pharma company rated on cultural relevance at all (C=50) reflects post-vaccine exhaustion. Business outpaces culture (B=52), yet -11.30% stock loss suggests markets doubt the next act.

IN THE NEWS (100 articles this week)
Moderna’s once-rebuffed mRNA flu shot to face scrutiny from FDA adcomm - BioSpace
FDA Plans Rare Advisory Hearing to Debate Moderna’s Flu Shot - Bloomberg.com
Moderna, Merck cancer combo cuts melanoma spread risk at five years - Reuters
Cultural Score
50 / 100
Business Score
52 / 100
TREND
TENSION▂▂▂▂▁▁▁▁▁▁▁▁▁▁
CULTURAL▄▄▄▄▄▄▄▄▄▄▄▄▄▄
BUSINESS▃▃▃▃▅▅▅▅▄▄▄▄▄▄
TREND CHART
Loading...
CULTURAL BREAKDOWN
Wikipedia Momentum 15/40
News Presence 36/35
Search InterestRedistributed to other dimensions
BUSINESS BREAKDOWN
Stock Momentum 8/30
Market Position 16/25
Revenue Growth 25/25
Earnings Health 3/20
STOCK DATA
Price$46.88
30d Change-11.3%
Market Cap$18.6B
Profit Margin-143.6%
BRANDS LIKE THIS
Gap
C:50 B:52 T:2
Walgreens
C:46 B:52 T:6
Lucid Motors
C:50 B:53 T:3
Walmart
C:50 B:51 T:1
Airtable
C:49 B:50 T:1
SHARE
Moderna's tension is 2. Commerce outpacing culture. sociologyofcapitalism.com/brand/moderna
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/moderna.html" width="320" height="200" frameborder="0"></iframe>
Data: Wikipedia Pageviews, Google News RSS, AI Sentiment, Yahoo Finance
All scores approximate. Updated daily.
Sociology of Capitalism
Mike Litman